Markets
BSE See NSE See 49,187.23
-1,852.08 (-3.63%)

Dr Reddy’s Laboratories announces launch of 2 separate products in Indian & US market

rishikesh gaikwad / Article rating: 4.3

Dr Reddy’s Laboratories Ltd announced the launch of Remdesivir along with its subsidiaries on Wednesday. The product is being launched under the brand name of Redyx in India. Additionally, it also announced the launch of over-the-counter (OTC) Diclofenac Sodium Topical Gel 1 per cent, the store brand version of Voltaren® Arthritis Pain in the US market.

Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection

rishikesh gaikwad / Article rating: 5.0

Alembic Pharmaceuticals Limited announced on Monday that its wholly-owned subsidiary, Alembic Global Holding SA has received tentative approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Treprostinil Injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials.

Strides Pharma receives USFDA approval for Prednisone tablets

rishikesh gaikwad / Article rating: 5.0

Strides Pharma Science Limited (Strides) announced on Thursday that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited (Singapore) has received approval for Prednisone tablets USP, 1 mg from United States Food & Drug Administration (USFDA). The product is a generic version of Meticorten tablets, 1 mg of Schering Corporation.

First2345791011Last

DSIJ MINDSHARE

12345Last

Knowledge

12